Heterogeneous absorption of antimicrobial peptide LL37 in <i>Escherichia coli</i> cells enhances population survivability.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 30560784.
- Also identified by DOI 10.7554/eLife.38174 and PMC identifier 6298785.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Antimicrobial peptides (AMPs) are broad spectrum antibiotics that selectively target bacteria. Here we investigate the activity of human AMP LL37 against <i>Escherichia coli</i> by integrating quantitative, population and single-cell level experiments with theoretical modeling. We observe an unexpected, rapid absorption and retention of a large number of LL37 peptides by <i>E. coli</i> cells upon the inhibition of their growth, which increases population survivability. This transition occurs more likely in the late stage of cell division cycles. Cultures with high cell density exhibit two distinct subpopulations: a non-growing population that absorb peptides and a growing population that survive owing to the sequestration of the AMPs by others. A mathematical model based on this binary picture reproduces the rather surprising observations, including the increase of the minimum inhibitory concentration with cell density (even in dilute cultures) and the extensive lag in growth introduced by sub-lethal dosages of LL37 peptides.
Medical subject headings
- Anti-Infective Agents
- Antimicrobial Cationic Peptides
- Escherichia coli
- Microbial Viability